Filed under Health · 2023
Pear Therapeutics
2013 - 2023, 10 years old
A prescription digital therapeutics company making FDA-cleared software apps for substance use disorder and insomnia.
Pear got FDA clearance for three prescription digital therapeutics including reSET and Somryst, but reimbursement from insurers never reached scale. The company went public via a $1.6B SPAC in late 2021 and shut down in April 2023.
- Founded
- 2013-01
- Shut down
- 2023-04-07
- Funding raised
- $396M
- Years alive
- 10
- Founders
- Corey McCann
Sources
Related departures
The Newsletter
New entries and essays by email.
Occasional dispatches when something dies. No spam. Unsubscribe anytime.